Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
PLoS Med
    September 2021
  1. CAIRNS M, Ceesay SJ, Sagara I, Zongo I, et al
    Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
    PLoS Med. 2021;18:e1003727.
    >> Share

    June 2021
  2. DEVINE A, Battle KE, Meagher N, Howes RE, et al
    Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    PLoS Med. 2021;18:e1003614.
    >> Share

  3. TONA LUTETE G, Mombo-Ngoma G, Assi SB, Bigoga JD, et al
    Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    PLoS Med. 2021;18:e1003669.
    >> Share

    May 2021
  4. WOODFORD J, Gillman A, Jenvey P, Roberts J, et al
    Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study.
    PLoS Med. 2021;18:e1003567.
    >> Share

  5. KHO S, Qotrunnada L, Leonardo L, Andries B, et al
    Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study.
    PLoS Med. 2021;18:e1003632.
    >> Share

    April 2021
  6. CHAVATTE JM, Snounou G
    Controlled human malaria infection-Maker and breaker of dogma.
    PLoS Med. 2021;18:e1003591.
    >> Share

  7. THRIEMER K, Ley B, von Seidlein L
    Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
    PLoS Med. 2021;18:e1003494.
    >> Share

  8. CHU CS, White NJ
    The prevention and treatment of Plasmodium vivax malaria.
    PLoS Med. 2021;18:e1003561.
    >> Share

    Taking on Plasmodium vivax malaria: A timely and important challenge.
    PLoS Med. 2021;18:e1003593.
    >> Share

  10. LEY B, Alam MS, Kibria MG, Marfurt J, et al
    Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
    PLoS Med. 2021;18:e1003576.
    >> Share

  11. NEKKAB N, Lana R, Lacerda M, Obadia T, et al
    Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    PLoS Med. 2021;18:e1003535.
    >> Share

  12. AUBURN S, Cheng Q, Marfurt J, Price RN, et al
    The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools.
    PLoS Med. 2021;18:e1003560.
    >> Share

    November 2020
  13. HOSSAIN MS, Commons RJ, Douglas NM, Thriemer K, et al
    The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
    PLoS Med. 2020;17:e1003393.
    >> Share

  14. HOGAN AB, Winskill P, Ghani AC
    Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    PLoS Med. 2020;17:e1003377.
    >> Share

    October 2020
  15. MOUSA A, Al-Taiar A, Anstey NM, Badaut C, et al
    The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis.
    PLoS Med. 2020;17:e1003359.
    >> Share

  16. STRESMAN G, Whittaker C, Slater HC, Bousema T, et al
    Quantifying Plasmodium falciparum infections clustering within households to inform household-based intervention strategies for malaria control programs: An observational study and meta-analysis from 41 malaria-endemic countries.
    PLoS Med. 2020;17:e1003370.
    >> Share

    September 2020
  17. COHEN JL, Leslie HH, Saran I, Fink G, et al
    Quality of clinical management of children diagnosed with malaria: A cross-sectional assessment in 9 sub-Saharan African countries between 2007-2018.
    PLoS Med. 2020;17:e1003254.
    >> Share

  18. HARTLEY MA, Hofmann N, Keitel K, Kagoro F, et al
    Clinical relevance of low-density Plasmodium falciparum parasitemia in untreated febrile children: A cohort study.
    PLoS Med. 2020;17:e1003318.
    >> Share

  19. LORENZ LM, Bradley J, Yukich J, Massue DJ, et al
    Comparative functional survival and equivalent annual cost of 3 long-lasting insecticidal net (LLIN) products in Tanzania: A randomised trial with 3-year follow up.
    PLoS Med. 2020;17:e1003248.
    >> Share

  20. O'BRIEN KS, Arzika AM, Maliki R, Manzo F, et al
    Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
    PLoS Med. 2020;17:e1003285.
    >> Share

    August 2020
  21. GALATAS B, Saute F, Marti-Soler H, Guinovart C, et al
    A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study.
    PLoS Med. 2020;17:e1003227.
    >> Share

  22. CAIRNS ME, Sagara I, Zongo I, Kuepfer I, et al
    Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Hounde District, Burkina Faso and Bougouni District, Mali.
    PLoS Med. 2020;17:e1003214.
    >> Share

  23. WATTS RE, Odedra A, Marquart L, Webb L, et al
    Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
    PLoS Med. 2020;17:e1003203.
    >> Share

  24. AGIUS PA, Cutts JC, Han Oo W, Thi A, et al
    Evaluation of the effectiveness of topical repellent distributed by village health volunteer networks against Plasmodium spp. infection in Myanmar: A stepped-wedge cluster randomised trial.
    PLoS Med. 2020;17:e1003177.
    >> Share

    May 2020
  25. PFEFFER DA, Ley B, Howes RE, Adu P, et al
    Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003084.
    >> Share

    March 2020
  26. CHAN XHS, Win YN, Haeusler IL, Tan JY, et al
    Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data.
    PLoS Med. 2020;17:e1003040.
    >> Share

  27. TUSTING LS, Gething PW, Gibson HS, Greenwood B, et al
    Housing and child health in sub-Saharan Africa: A cross-sectional analysis.
    PLoS Med. 2020;17:e1003055.
    >> Share

    December 2019
  28. LEY B, Winasti Satyagraha A, Rahmat H, von Fricken ME, et al
    Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
    PLoS Med. 2019;16:e1002992.
    >> Share

    October 2019
  29. ELPHINSTONE RE, Weckman AM, McDonald CR, Tran V, et al
    Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
    PLoS Med. 2019;16:e1002914.
    >> Share

  30. VON SEIDLEIN L, Wood H, Brittain OS, Tusting L, et al
    Knowledge gaps in the construction of rural healthy homes: A research agenda for improved low-cost housing in hot-humid Africa.
    PLoS Med. 2019;16:e1002909.
    >> Share

  31. COMMONS RJ, Simpson JA, Thriemer K, Abreha T, et al
    The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.
    PLoS Med. 2019;16:e1002928.
    >> Share

    August 2019
  32. LEOPOLD SJ, Watson JA, Jeeyapant A, Simpson JA, et al
    Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies.
    PLoS Med. 2019;16:e1002858.
    >> Share

    June 2019
  33. ARZIKA AM, Maliki R, Boubacar N, Kane S, et al
    Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
    PLoS Med. 2019;16:e1002835.
    >> Share

    May 2019
  34. KENANGALEM E, Poespoprodjo JR, Douglas NM, Burdam FH, et al
    Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.
    PLoS Med. 2019;16:e1002815.
    >> Share

  35. PHAM TV, Nguyen HV, Aguirre AR, Nguyen VV, et al
    Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam.
    PLoS Med. 2019;16:e1002784.
    >> Share

    March 2019
  36. NDIAYE JLA, Ndiaye Y, Ba MS, Faye B, et al
    Seasonal malaria chemoprevention combined with community case management of malaria in children under 10 years of age, over 5 months, in south-east Senegal: A cluster-randomised trial.
    PLoS Med. 2019;16:e1002762.
    >> Share

    February 2019
  37. VON SEIDLEIN L, Peto TJ, Landier J, Nguyen TN, et al
    The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
    PLoS Med. 2019;16:e1002745.
    >> Share

  38. BHATIA T, Enoch J, Khan M, Mathewson S, et al
    Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?
    PLoS Med. 2019;16:e1002735.
    >> Share

    July 2018
  39. JAGANNATHAN P, Kakuru A, Okiring J, Muhindo MK, et al
    Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    PLoS Med. 2018;15:e1002606.
    >> Share

  40. PRUDHOMME O'MEARA W, Menya D, Laktabai J, Platt A, et al
    Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.
    PLoS Med. 2018;15:e1002607.
    >> Share

    June 2018
  41. KLOPROGGE F, Workman L, Borrmann S, Tekete M, et al
    Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
    PLoS Med. 2018;15:e1002579.
    >> Share

    November 2017
  42. WINSKILL P, Slater HC, Griffin JT, Ghani AC, et al
    The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study.
    PLoS Med. 2017;14:e1002448.
    >> Share

  43. malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002450.
    >> Share

  44. RABINOVICH RN, Drakeley C, Djimde AA, Hall BF, et al
    malERA: An updated research agenda for malaria elimination and eradication.
    PLoS Med. 2017;14:e1002456.
    >> Share

  45. malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002453.
    >> Share

  46. malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002455.
    >> Share

  47. malERA: An updated research agenda for health systems and policy research in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002454.
    >> Share

  48. malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002452.
    >> Share

  49. malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002451.
    >> Share

    October 2017
  50. LOVER AA, Harvard KE, Lindawson AE, Smith Gueye C, et al
    Regional initiatives for malaria elimination: Building and maintaining partnerships.
    PLoS Med. 2017;14:e1002401.
    >> Share

  51. DECHAVANNE C, Dechavanne S, Sadissou I, Lokossou AG, et al
    Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
    PLoS Med. 2017;14:e1002403.
    >> Share

    August 2017
  52. CATES JE, Unger HW, Briand V, Fievet N, et al
    Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.
    PLoS Med. 2017;14:e1002373.
    >> Share

  53. DOUGLAS NM, Poespoprodjo JR, Patriani D, Malloy MJ, et al
    Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.
    PLoS Med. 2017;14:e1002379.
    >> Share

    June 2017
    Malaria control adds to the evidence for health aid effectiveness.
    PLoS Med. 2017;14:e1002320.
    >> Share

  55. JAKUBOWSKI A, Stearns SC, Kruk ME, Angeles G, et al
    The US President's Malaria Initiative and under-5 child mortality in sub-Saharan Africa: A difference-in-differences analysis.
    PLoS Med. 2017;14:e1002319.
    >> Share

    May 2017
  56. ABREHA T, Hwang J, Thriemer K, Tadesse Y, et al
    Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
    PLoS Med. 2017;14:e1002299.
    >> Share

    February 2017
  57. CHU CS, Bancone G, Moore KA, Win HH, et al
    Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    PLoS Med. 2017;14:e1002224.
    >> Share

  58. TUSTING LS, Bottomley C, Gibson H, Kleinschmidt I, et al
    Housing Improvements and Malaria Risk in Sub-Saharan Africa: A Multi-Country Analysis of Survey Data.
    PLoS Med. 2017;14:e1002234.
    >> Share

  59. WALKER PG, Floyd J, Ter Kuile F, Cairns M, et al
    Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    PLoS Med. 2017;14:e1002243.
    >> Share

  60. BEESON JG, Simpson JA
    The potential benefit of scaling up malaria prevention to reduce low birth weight in Africa.
    PLoS Med. 2017;14:e1002244.
    >> Share

    January 2017
  61. HOGLUND RM, Workman L, Edstein MD, Thanh NX, et al
    Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.
    PLoS Med. 2017;14:e1002212.
    >> Share

    November 2016
  62. KATUREEBE A, Zinszer K, Arinaitwe E, Rek J, et al
    Measures of Malaria Burden after Long-Lasting Insecticidal Net Distribution and Indoor Residual Spraying at Three Sites in Uganda: A Prospective Observational Study.
    PLoS Med. 2016;13:e1002167.
    >> Share

  63. SNOW RW
    Seasonal Malaria Chemoprevention: An Evolving Research Paradigm.
    PLoS Med. 2016;13:e1002176.
    >> Share

  64. CISSE B, Ba EH, Sokhna C, NDiaye JL, et al
    Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
    PLoS Med. 2016;13:e1002175.
    >> Share

    September 2016
  65. MADANITSA M, Kalilani L, Mwapasa V, van Eijk AM, et al
    Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlle
    PLoS Med. 2016;13:e1002124.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016